# Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Source: https://onco.cc/trials/nct00104741/  
OnCo record `nct00104741` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Flutamide and Triptorelin in Prostate cancer, run by UNICANCER, completed.

## Summary

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer is a phase 3 interventional study registered as NCT00104741 by UNICANCER, with 378 participants recorded, started 2003-09-10 and reaching its primary completion in 2015-10. Interventions recorded: flutamide, triptorelin, radiation therapy. Conditions recorded: Prostate Cancer.

Linked to the drug Flutamide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00104741
- Phase: 3
- Setting: Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis
- Sponsor: UNICANCER
- Enrolled: 378

## Sources

- ClinicalTrials.gov NCT00104741: https://clinicaltrials.gov/study/NCT00104741

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Flutamide](https://onco.cc/drugs/flutamide/), [Triptorelin](https://onco.cc/drugs/triptorelin/)

---
JSON: https://onco.cc/api/v1/entities/nct00104741.json